{"id":"W3176370909","doi":"10.1016/s2352-3026(21)00134-4","title":"CPX-351 versus 7+3 cytarabine and daunorubicin chemotherapy in older adults with newly diagnosed high-risk or secondary acute myeloid leukaemia: 5-year results of a randomised, open-label, multicentre, phase 3 trial","year":2021,"lang":"en","type":"article","venue":"The Lancet Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":211,"is_retracted":false,"has_abstract":false,"ca_institutions":"Leukemia & Lymphoma Society of Canada","funders":"Celator Pharmaceuticals; Jazz Pharmaceuticals","keywords":"Medicine; Cytarabine; Daunorubicin; Internal medicine; Myeloid leukemia; Chemotherapy; Myeloid leukaemia; Chemotherapy regimen; Oncology; Pediatrics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001192342,0.0004134268,0.002563389,0.0001783888,0.0001176051,0.00004622597,0.00059785,0.0003245366,0.0003095677],"category_scores_gemma":[0.001526965,0.0002499864,0.00006826344,0.000695057,0.0005087961,0.0001707244,0.0003383357,0.001185017,0.00002141277],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000169547,"about_ca_system_score_gemma":0.001238521,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001266961,"about_ca_topic_score_gemma":0.002125437,"domain_scores_codex":[0.9961975,0.0008263701,0.0009297844,0.0008186714,0.0004052322,0.0008224277],"domain_scores_gemma":[0.9951868,0.002656147,0.0004648045,0.001208741,0.0002634085,0.0002200827],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9700589,0.001455117,0.0005685987,0.0002878036,0.0007537687,0.005616505,0.002590045,0.000004871837,0.001403714,0.0001267818,0.008086095,0.009047871],"study_design_scores_gemma":[0.9788458,0.003946984,0.001415423,0.0004374757,0.0004521966,0.0008407798,0.00129265,0.0004333918,0.01108204,0.00004083581,0.0009293876,0.0002830784],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9845513,0.0007347346,0.00003811839,0.009053932,0.0002359362,0.004319117,0.0002709223,0.00005200028,0.0007439591],"genre_scores_gemma":[0.984178,0.007146873,0.005405994,0.001310097,0.0003956526,0.0003935263,0.0003293854,0.00009687276,0.0007435752],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009678324,"threshold_uncertainty_score":0.9999952,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03108454719582305,"score_gpt":0.3381754923427316,"score_spread":0.3070909451469086,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}